adverse-event

Documents about adverse-event

• Implementation of a Pharmacist-led Pharmacogenomic Clinical Service#908306ClinicalTrials.gov
• 21 U.S.C. § 379aa-1 — Serious adverse event reporting for dietary supplements#577244US Code (LII)
• Frequency and Medical Costs of Hypersensitivity- and Anaphylaxis-Related Adverse Events for Different Intravenous Iron Products Using the US Food and Drug Administration Adverse Event Reporting System (FAERS)#241494bioRxiv / medRxiv
• Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis#346910ClinicalTrials.gov
• Hip-Fracture Surgery on Patients in Clopidogrel Therapy#832315ClinicalTrials.gov
• Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysis#818531HAL (France)
• faers: A High-Fidelity Framework and R/Bioconductor Package for Precision Adverse Event Surveillance#134318bioRxiv / medRxiv
• Quantitative lung tissue functional analysis for pulmonary adverse event risk assessment prior to thoracic radiotherapy.#338421NCBI PubMed Central
• Radial Artery Patency and Bleeding, Efficacy, Adverse evenT Trial#802308ClinicalTrials.gov
• Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia#875309ClinicalTrials.gov
• faers: A High-Fidelity Framework and R/Bioconductor Package for Precision Adverse Event Surveillance#138337Unpaywall
• Human Papillomavirus Vaccination and Premature Ovarian Failure: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System#242873Ora Oxford University Research
• Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy#332755ClinicalTrials.gov
• Impact of OCT on Outcomes in AMI#807029ClinicalTrials.gov
• Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study#828395ClinicalTrials.gov
• Monitoring the IMmUological TOXicity of Drugs#857429ClinicalTrials.gov
• Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors#268893IRIS
• Ipilimumab and nivolumab for cancer treatment: a pharmacovigilance study based on the FDA adverse event reporting system database.#338507NCBI PubMed Central
• Assessing the Completeness of Adverse Event Reporting in Clinical Trials of Psoriasis Treatments: A Registry-Publication Comparison Study.#345273NCBI PubMed Central
• Real-world adverse event profiles of Zuranolone and Brexanolone based on FAERS and VigiAccess databases: An observational study.#388625NCBI PubMed Central
• Development and application of the vaccine reporting quality score to evaluate the vaccine adverse event reporting system.#476889NCBI PubMed Central
• Failure modes of robotic-assisted arthroplasty platforms in Australia: a descriptive analysis of TGA adverse event reports.#659694NCBI PubMed Central
• An EORTC Study Updating the QLQ-BR23 to BR45#868088ClinicalTrials.gov
• Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis#870148ClinicalTrials.gov
• Incidence of Hemocompatibility Events With or Without Aspirin in Patients With CH-VAD#873208ClinicalTrials.gov
• Cancer Patients Treated With Immunotherapy in Intensive Care Unit#909256ClinicalTrials.gov
• Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions#900322ClinicalTrials.gov
• Developing a natural language processing system using transformer-based models for adverse drug event detection in electronic health records.#334790NCBI PubMed Central
• Safety of Pediatric COVID-19 Vaccination#879167ClinicalTrials.gov
• Long-acting G-CSF for Febrile Neutropenia#882805ClinicalTrials.gov
• VigiBase: Resource Profile Update with a Summary of Global Patterns and Trends in Adverse Event Reports for Medicines and Vaccines.#182507NCBI PubMed Central
• Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial#253058ClinicalTrials.gov
• Intelligent Framework for Adverse Drug Event Identification Using Large Language Models and Retrieval-Augmented Generation: Development and Evaluation Study.#446314NCBI PubMed Central
• Invisible Harms, Visible Benefits? Adverse Event Reporting in Physical Activity Interventions for Neurodevelopmental Disorders: A Meta-analysis and Critical Appraisal.#645198NCBI PubMed Central
• Pemphigoid associated with quinolone antibiotics: a real-world pharmacovigilance study of the FDA adverse event reporting system and literature-based evidence.#148327NCBI PubMed Central
• Comparative Analysis of Potential Side Effects of Targeted Oral Hypoglycemic Agents Using Spontaneous Adverse Event Reports and Social Media Data.#156871NCBI PubMed Central
• Correction: Determinants of adverse event occurrence in children with short stature born small for gestational age treated with growth hormone#161278HAL (France)
• Real-world safety profile of Enfortumab Vedotin: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS)#349783bioRxiv / medRxiv
• Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer#383566ClinicalTrials.gov
• PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae#407750ClinicalTrials.gov
• Adverse event reporting and regulatory analysis of pediatric cardiac assist devices#450187PLOS
• Adverse Events and ABC Pathway Adherence Across AF Clinical Phenotypes: APHRS-AF Registry Cluster Analysis Study#482806IRIS
• The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy#852188ClinicalTrials.gov
• World alliance for patient safety: WHO draft guidelines for adverse event reporting and learning systems: from information to action#451022WHO IRIS
• Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy#801843ClinicalTrials.gov
• Maxillary sinus-related adverse event reports associated with endosseous dental implants in the FDA MAUDE database: a retrospective text-mining analysis.#340421NCBI PubMed Central
• The real-world safety profile of amitriptyline: A comprehensive pharmacovigilance analysis based on the large-scale FDA adverse event reporting system database.#396223NCBI PubMed Central
• Real‑world analysis of Macular Oedema associated with Paclitaxel Formulations using the Japanese Adverse Drug Event Report database#412839PLOS
• Safety of Antiepileptic Withdrawal in Long Term Video-EEG Monitoring#886377ClinicalTrials.gov
• Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes#892278ClinicalTrials.gov